Additional studies have provided evidence to support a role for an inverse association between the A/L ratio and breast cancer risk and prognosis (Chen et al. 2006; Goodwin et al. 2012), suggesting the balance of adiponectin and leptin, rather than either biomarker alone, may also be clinically significant. The gene discussed is LEP; the disease is breast cancer.